Did you know that The Center for Cancer conducts clinical trials?

A clinical trial is a research study that is designed to determine if a new drug or treatment will work on a disease or will potentially be beneficial to patients. Clinical trials allow doctors and researchers to gain information on the benefits, side effects, and possible new treatments for a particular disease. It also creates alternative therapies that may not otherwise be available to patients.

Regional cancer centers, national cancer research groups, and pharmaceutical companies have designated The Center for Cancer as a clinical research site. We conduct multiple phase II-IV clinical trials in the therapeutic and supportive care areas of Oncology and Hematology.

The Center for Cancer's Clinical Trials team is comprised of physicians, nurses, study coordinators, pharmacy, laboratory technicians and other dedicated staff members. Our group of clinical research personnel is committed to providing patients with the latest developments in disease treatment and management.

View all of our Open Trials at ClinicalTrials.gov

See Also - Active Breast Studies with Virtua-Fox Chase Cancer Center:

NCT00769379
NSABP, B-43 is a phase III clinical trial comparing Trastuzumab given concurrently with radiation therapy to radiation therapy alone for women with HER2Neu positive (+) Ductal Carcinoma in Situ (DCIS) resected by lumpectomy.

NCT00066703
CTSU (IBCSG), 25-02 is a phase III trial evaluating Exemestane plus GnRH analogue as adjuvant therapy for endocrine responsive breast cancer.

NCT00433511
ECOG, 5103 is a double-blinded phase III trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in patients with lymph node negative (-) breast cancer.

NCT00310180
ECOG, PACCT-1 is a program for the assessment of clinical cancer tests; trial assigning individualized options for treatment:  The Tailor X Trial.

For more information, ask your doctor or call us at 856-424-3311 x 1702.